Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Borget

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Endocrine|July 22, 2020
Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancerHelton Estrela Ramos, Fabio Hecht, Amandine Berdelou, et al.
British Journal of Cancer|July 3, 2026
The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab aloneAna Cavillon, Isabelle Borget, Caroline Robert, et al.
Journal of Evaluation in Clinical Practice|March 25, 2018
Single-use flexible bronchoscopes compared with reusable bronchoscopes: Positive organizational impact but a costly solutionConstance Châteauvieux, Line Farah, Emmanuel Guérot, et al.
International Journal of Technology Assessment in Health Care|June 6, 2017
HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?Nicolas Martelli, Capucine Devaux, Hélène van den Brink, et al.
JCO Clinical Cancer Informatics|September 21, 2019
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2Guillaume Beinse, Virgile Tellier, Valentin Charvet, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Assessment of Performance, Interpretability, and Explainability in Artificial Intelligence-Based Health Technologies: What Healthcare Stakeholders Need to KnowLine Farah, Juliette M Murris, Isabelle Borget, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 20, 2026
Lesional dosimetry in <sup>131</sup>I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodineNadège Anizan, Alexandre Pignard, Isabelle Borget, et al.
Surgery|February 3, 2016
Advantages and disadvantages of 3-dimensional printing in surgery: A systematic reviewNicolas Martelli, Carole Serrano, Hélène van den Brink, et al.
Academic Radiology|February 8, 2012
Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experienceMarie-Laure Chabi, Isabelle Borget, Rosario Ardiles, et al.
The Breast Journal|June 4, 2014
Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patientsAntonin Levy, Isabelle Borget, Manel Bahri, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Endocrine|July 22, 2020
Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancerHelton Estrela Ramos, Fabio Hecht, Amandine Berdelou, et al.
British Journal of Cancer|July 3, 2026
The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab aloneAna Cavillon, Isabelle Borget, Caroline Robert, et al.
Journal of Evaluation in Clinical Practice|March 25, 2018
Single-use flexible bronchoscopes compared with reusable bronchoscopes: Positive organizational impact but a costly solutionConstance Châteauvieux, Line Farah, Emmanuel Guérot, et al.
International Journal of Technology Assessment in Health Care|June 6, 2017
HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?Nicolas Martelli, Capucine Devaux, Hélène van den Brink, et al.
JCO Clinical Cancer Informatics|September 21, 2019
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2Guillaume Beinse, Virgile Tellier, Valentin Charvet, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Assessment of Performance, Interpretability, and Explainability in Artificial Intelligence-Based Health Technologies: What Healthcare Stakeholders Need to KnowLine Farah, Juliette M Murris, Isabelle Borget, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 20, 2026
Lesional dosimetry in <sup>131</sup>I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodineNadège Anizan, Alexandre Pignard, Isabelle Borget, et al.
Surgery|February 3, 2016
Advantages and disadvantages of 3-dimensional printing in surgery: A systematic reviewNicolas Martelli, Carole Serrano, Hélène van den Brink, et al.
Academic Radiology|February 8, 2012
Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experienceMarie-Laure Chabi, Isabelle Borget, Rosario Ardiles, et al.
The Breast Journal|June 4, 2014
Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patientsAntonin Levy, Isabelle Borget, Manel Bahri, et al.
Pageof 14